Search Within

David Hyman

  1. "Radiology, Department of"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (16)
Groups
  1. Department of Medicine (46)
  2. Early Drug Development Service (46)
  3. Radiology, Department of (46)
  4. Solid Tumor Oncology Division (46)
  5. GSK Faculty (35)
  6. Department of Pathology and Laboratory Medicine (30)

More Groups

People
  1. Gary Ulaner (22)
  2. David Solit (16)
  3. Eli Diamond (15)
  4. Alexander Drilon (13)
  5. Omar Abdel-Wahab (13)
  6. Michael Berger (12)

More People

Years
  1. 2021 (1)
  2. 2020 (6)
  3. 2019 (10)
  4. 2018 (8)
  5. 2017 (10)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. JCO Precision Oncology (5)
  3. Cancer Discovery (4)
  4. Blood (3)
  5. Clinical Cancer Research (3)
  6. Pediatric Blood and Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (8)
  3. Lippincott Williams & Wilkins (4)
  4. American Society of Hematology (3)
  5. Nature Publishing Group (3)
  6. Springer (3)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
    Journal Article

    Hyman, D. M.; Snyder, A. E.; Carvajal, R. D.; Gerecitano, J. F.; Voss, M. H.; Ho, A. L.; Konner, J.; Winkelmann, J. L.; Stasi, M. A.; Monson, K. R.; more...
    Cancer Chemotherapy and Pharmacology (2015)

    Fulltext@MSK | Save
  • Visualization of orbital involvement of Erdheim-Chester disease on PET/CT
    Journal Article

    Beylergil, V.; Carrasquillo, J. A.; Hyman, D. M.; Diamond, E. L.
    Clinical Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Gemcitabine for advanced endometrial cancer: A retrospective study of the Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Grisham, R. N.; Adaniel, C.; Hyman, D. M.; Ma, W.; Iasonos, A.; Aghajanian, C.; Konner, J.
    International Journal of Gynecological Cancer (2012)

    Fulltext@MSK | Save
  • Gemcitabine for advanced endometrial carcinoma (EMC): A review of the MSKCC experience
    Meeting Abstract

    Grisham, R. N.; Adaniel, C. H.; Hyman, D. M.; Ma, W.; Iasonos, A.; Aghajanian, C.; Konner, J. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save